Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

895 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adalimumab in Patients with Active Noninfectious Uveitis.
Jaffe GJ, Dick AD, Brézin AP, Nguyen QD, Thorne JE, Kestelyn P, Barisani-Asenbauer T, Franco P, Heiligenhaus A, Scales D, Chu DS, Camez A, Kwatra NV, Song AP, Kron M, Tari S, Suhler EB. Jaffe GJ, et al. Among authors: franco p. N Engl J Med. 2016 Sep 8;375(10):932-43. doi: 10.1056/NEJMoa1509852. N Engl J Med. 2016. PMID: 27602665 Free article. Clinical Trial.
Intravitreal Sirolimus for Noninfectious Uveitis: A Phase III Sirolimus Study Assessing Double-masKed Uveitis TReAtment (SAKURA).
Nguyen QD, Merrill PT, Clark WL, Banker AS, Fardeau C, Franco P, LeHoang P, Ohno S, Rathinam SR, Thurau S, Abraham A, Wilson L, Yang Y, Shams N; Sirolimus study Assessing double-masKed Uveitis tReAtment (SAKURA) Study Group. Nguyen QD, et al. Among authors: franco p. Ophthalmology. 2016 Nov;123(11):2413-2423. doi: 10.1016/j.ophtha.2016.07.029. Epub 2016 Sep 28. Ophthalmology. 2016. PMID: 27692526 Free article. Clinical Trial.
Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterior Segment: Results from the Sirolimus Study Assessing Double-Masked Uveitis Treatment (SAKURA) Program.
Merrill PT, Clark WL, Banker AS, Fardeau C, Franco P, LeHoang P, Ohno S, Rathinam SR, Ali Y, Mudumba S, Shams N, Nguyen QD; Sirolimus Study Assessing Double-Masked Uveitis Treatment (SAKURA) Study Group. Merrill PT, et al. Among authors: franco p. Ophthalmology. 2020 Oct;127(10):1405-1415. doi: 10.1016/j.ophtha.2020.03.033. Epub 2020 Apr 3. Ophthalmology. 2020. PMID: 32564920 Free article. Clinical Trial.
Noninfectious Intermediate, Posterior, or Panuveitis: Results from the Retrospective, Observational, International EyeCOPE Study.
Kramer M, Brichova M, Tugal-Tutkun I, Panchenko M, Gormezano N, Koenigsbauer F, Franco P, Muccioli C, Hasanreisoglu M; International EyeCOPE Study Group. Kramer M, et al. Among authors: franco p. Ophthalmol Ther. 2021 Sep;10(3):565-580. doi: 10.1007/s40123-021-00351-4. Epub 2021 Jun 12. Ophthalmol Ther. 2021. PMID: 34117983 Free PMC article.
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
Bacterial lipopolysaccharide protects the retina from light-induced damage.
Bordone MP, Lanzani MF, López-Costa JJ, Chianelli MS, Franco P, Sáenz DA, Rosenstein RE. Bordone MP, et al. Among authors: franco p. J Neurochem. 2012 Jul;122(2):392-403. doi: 10.1111/j.1471-4159.2012.07767.x. Epub 2012 May 23. J Neurochem. 2012. PMID: 22536982 Free article.
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Ophthalmology. 2024 Feb 19:S0161-6420(24)00134-9. doi: 10.1016/j.ophtha.2024.02.014. Online ahead of print. Ophthalmology. 2024. PMID: 38382813 Free article.
895 results